Silencing of PTPN18 Induced Ferroptosis in Endometrial Cancer Cells Through p-P38-Mediated GPX4/xCT Down-Regulation

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Makker A, Goel MM. Tumor progression, metastasis, and modulators of epithelial-mesenchymal transition in endometrioid endometrial carcinoma: an update. Endocr Relat Cancer. 2016;23(2):R85–R111. doi:10.1530/ERC-15-021826538531
   PubMed Web of Science ®Google Scholar
• Chaudhry P, Asselin E. Resistance to chemotherapy and hormone therapy in endometrial cancer. Endocr Relat Cancer. 2009;16(2):363–380. doi:10.1677/ERC-08-026619190080
   PubMed Web of Science ®Google Scholar
• Decruze SB, Green JA. Hormone therapy in advanced and recurrent endometrial cancer: a systematic review. Int J Gynecol Cancer. 2007;17(5):964–978. doi:10.1111/j.1525-1438.2007.00897.x17442022
   PubMed Web of Science ®Google Scholar
• Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E. Endometrial cancer. Lancet. 2016;387(10023):1094–1108. doi:10.1016/S0140-6736(15)00130-026354523
   PubMed Web of Science ®Google Scholar
• Lin X, Ping J, Wen Y, Wu Y. The mechanism of ferroptosis and applications in tumor treatment. Front Pharmacol. 2020;11:1061. doi:10.3389/fphar.2020.0106132774303
   PubMed Web of Science ®Google Scholar
• Lu D, Yang Z, Xia Q, et al. ACADSB regulates ferroptosis and affects the migration, invasion and proliferation of colorectal cancer cells. Cell Biol Int. 2020;44(11):2334–2343. doi:10.1002/cbin.1144332776663
   PubMed Web of Science ®Google Scholar
• Guan Z, Chen J, Li X, Dong N. Tanshinone IIA induces ferroptosis in gastric cancer cells through p53 mediated-SLC7A11 down-regulation. Biosci Rep. 2020;40(8). doi:10.1042/BSR20201807
   Web of Science ®Google Scholar
• Hasan M, Reddy SM, Das NK. Ferritinophagy is not required for colon cancer cell growth. Cell Biol Int. 2020;44(11):2307–2314. doi:10.1002/cbin.1143932767706
   PubMed Web of Science ®Google Scholar
• Yao X, Yang B, Wang S, et al. A novel multifunctional FePt/BP nanoplatform for synergistic photothermal/photodynamic/chemodynamic cancer therapies and photothermally-enhanced immunotherapy. J Mater Chem B. 2020;8(35):8010–8021. doi:10.1039/D0TB00411A32766612
   PubMed Web of Science ®Google Scholar
• Held MA, Greenfest-Allen E, Su S, Stoeckert CJ, Stokes MP, Wojchowski DM. Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR/JAK2 signaling. Cell Signal. 2020;69:109554. doi:10.1016/j.cellsig.2020.10955432027948
   PubMed Web of Science ®Google Scholar
• Chen J, Zhao X, Yuan Y, Jing JJ. The expression patterns and the diagnostic/prognostic roles of PTPN family members in digestive tract cancers. Cancer Cell Int. 2020;20(1):238. doi:10.1186/s12935-020-01315-732536826
   PubMed Web of Science ®Google Scholar
• Zhangyuan G, Yin Y, Zhang W, et al. Prognostic value of phosphotyrosine phosphatases in hepatocellular carcinoma. Cell Physiol Biochem. 2018;46(6):2335–2346. doi:10.1159/00048962529742497
   PubMedGoogle Scholar
• Lucci MA, Orlandi R, Triulzi T, Tagliabue E, Balsari A, Villa-Moruzzi E. Expression profile of tyrosine phosphatases in HER2 breast cancer cells and tumors. Cell Oncol. 2010;32(5–6):361–372. doi:10.3233/CLO-2010-052020413845
   PubMed Web of Science ®Google Scholar
• Cai J, Huang S, Yi Y, Bao S. Downregulation of PTPN 18 can inhibit proliferation and metastasis and promote apoptosis of endometrial cancer. Clin Exp Pharmacol Physiol. 2019;46(8):734–742. doi:10.1111/1440-1681.1309831034093
   PubMed Web of Science ®Google Scholar
• Ozawa H. Principles and basics of immunohistochemistry. Nippon Yakurigaku Zasshi. 2019;154(4):156–164. doi:10.1254/fpj.154.15631597893
   PubMedGoogle Scholar
• Stockwell BR, Friedmann Angeli JP, Bayir H, et al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171(2):273–285. doi:10.1016/j.cell.2017.09.02128985560
   PubMed Web of Science ®Google Scholar
• Sun X, Ou Z, Chen R, et al. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology. 2016;63(1):173–184. doi:10.1002/hep.2825126403645
   PubMed Web of Science ®Google Scholar
• Gao Z, Deng G, Li Y, et al. Actinidia chinensis planch prevents proliferation and migration of gastric cancer associated with apoptosis, ferroptosis activation and mesenchymal phenotype suppression. Biomed Pharmacother. 2020;126:110092. doi:10.1016/j.biopha.2020.11009232203890
   PubMed Web of Science ®Google Scholar
• Zhou HH, Chen X, Cai LY, et al. Erastin reverses ABCB1-mediated docetaxel resistance in ovarian cancer. Front Oncol. 2019;9:1398. doi:10.3389/fonc.2019.0139831921655
   PubMed Web of Science ®Google Scholar
• Eling N, Reuter L, Hazin J, Hamacher-Brady A, Brady NR. Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells. Oncoscience. 2015;2(5):517–532. doi:10.18632/oncoscience.16026097885
   PubMedGoogle Scholar
• Roh JL, Kim EH, Jang H, Shin D. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis. Redox Biol. 2017;11:254–262. doi:10.1016/j.redox.2016.12.01028012440
   PubMed Web of Science ®Google Scholar
• Chen MS, Wang SF, Hsu CY, et al. CHAC1 degradation of glutathione enhances cystine-starvation-induced necroptosis and ferroptosis in human triple negative breast cancer cells via the GCN2-eIF2alpha-ATF4 pathway. Oncotarget. 2017;8(70):114588–114602. doi:10.18632/oncotarget.2305529383104
   PubMedGoogle Scholar
• Skouta R, Dixon SJ, Wang J, et al. Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J Am Chem Soc. 2014;136(12):4551–4556. doi:10.1021/ja411006a24592866
   PubMed Web of Science ®Google Scholar
• Forcina GC, Dixon SJ. GPX4 at the crossroads of lipid homeostasis and ferroptosis. Proteomics. 2019;19(18):e1800311. doi:10.1002/pmic.20180031130888116
   PubMed Web of Science ®Google Scholar
• Hasegawa M, Takahashi H, Rajabi H, et al. Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells. Oncotarget. 2016;7(11):11756–11769. doi:10.18632/oncotarget.759826930718
   PubMedGoogle Scholar
• Donohoe F, Wilkinson M, Baxter E, Brennan DJ. Mitogen-activated protein kinase (MAPK) and obesity-related cancer. Int J Mol Sci. 2020;21(4):1241. doi:10.3390/ijms21041241
   PubMed Web of Science ®Google Scholar
• Ye Q, Zeng C, Luo C, Wu Y. Ferrostatin-1 mitigates cognitive impairment of epileptic rats by inhibiting P38 MAPK activation. Epilepsy Behav. 2020;103:106670. doi:10.1016/j.yebeh.2019.10667031864943
   PubMed Web of Science ®Google Scholar
• Hattori K, Ishikawa H, Sakauchi C, Takayanagi S, Naguro I, Ichijo H. Cold stress-induced ferroptosis involves the ASK 1-p38 pathway. EMBO Rep. 2017;18(11):2067–2078. doi:10.15252/embr.20174422828887319
   PubMed Web of Science ®Google Scholar